Medicament for inhibiting nf-kb

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/519 (2006.01) A61P 19/02 (2006.01) A61P 25/28 (2006.01) A61P 29/00 (2006.01)

Patent

CA 2369448

Compounds of formula (I) (see formula I) wherein R1 through R8 are selected independently from hydrogen atoms and pharmaceutically acceptable substituents, as well as pharmaceutically acceptable salts of compounds of formula (I) and mixtures of substances containing at least one compound of formula (I) or a pharmaceutically acceptable salt thereof are used for preparation of medicaments for inhibiting transcription factor NF-.kappa.B and/or for inhibiting COX with a preferential inhibitory effect for COX-2.

L'invention concerne des composés de la formule (I) dans laquelle R<1> à R<8> compris sont sélectionnés indépendamment les uns des autres parmi les atomes d'hydrogène et des substituants pharmaceutiquement acceptables, ainsi que des sels acceptables des composés de la formule (I) et des mélanges de substances qui contiennent au moins un composé de la formule (I) ou son sel pharmaceutiquement acceptable. Ces composés s'utilisent pour préparer des médicaments permettant d'inhiber le facteur de transmission NF- kappa B et/ou d'inhiber le COX avec un effet inhibiteur préférentiel pour le COX-2 et/ou d'inhiber la libération d'histamine et/ou de sérotonine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Medicament for inhibiting nf-kb does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicament for inhibiting nf-kb, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament for inhibiting nf-kb will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1645432

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.